Senior professional support lawyer Paul England and Matthew Royle, partner in the life sciences team at international law firm Taylor Wessing discuss what the introduction of a manufacturing waiver to the SPC legislation means for manufacturers.
Martin Gadsby, director at Optimal Industrial Technologies, looks at how Process Analytical Technology (PAT) can speed up the development and production of new and existing drugs.
Rich Quelch, global head of marketing, Origin, looks at how Brexit will affect regulatory bodies in the UK and how this impacts pharmaceutical packagers.
Tatsiana Levdikova, content marketer at OpenLedger ApS, a blockchain development company, writes about the opioid epidemic in the US and if blockchain is the answer.
Ursula Hahn, head of product management, Sanner, Germany, looks at how both moisture and odour can be systematically prevented using suitable adsorbents – provided the right aspects are taken into account.
Rod Schregardus, supply chain specialist at Access Group, looks at the growing importance of Advanced Planning and Scheduling (APS) systems in pharmaceuticals.
David Staunton, global director services at Zenith Technologies and Scott Ripley, global marketing director at GE Healthcare, discuss the benefits of single-use technology and how patients are the ultimate beneficiaries.
